Christophers, J., J. Clayton, J. Craske, R. Ward, P. Collins, M. Trowbridge, and G. Darby.  1998.  Survey of resistance of herpes simplex virus to acyclovir in Northwest England.  Antimicrobial Agents and Chemotherapy.  42:868-872.

Corey, L., K.H. Fife, and J.K. Benedetti.  1983.  Intravenous acyclovir for the treatment of primary genital herpes.  Annals of Internal Medicine.  98:914-921.

Furman, P.A., M.H. St. Clair, and R. Spector.  1984.  Acyclovir triphosphate is a suicide inactivator of the herpes simplex virus DNA polymerase.  Journal of Biological Chemistry.  259: 9575-9579.

JAMA: Women's Health[ONLINE]  [4/16/01, last day accessed.]

Lazarus, H.M., R. Belanger, A. Candoni, M. Aoun, R. Jurewicz, L. Marks, and The Penciclovir Immunocompromised Study Group.  1999.   Intravenous penciclovir for treatment of herpes simplex infections in immunocompromised patients: results of a multicenter, acyclovir-controlled trial.  Antimicrobial Agents and Chemotherapy.  43:1192-1197.

Miller, C.  Australian Herpes Management Forum (AHMF).  [ONLINE]  [3/27/01, last date accessed.]

Molecules "R" Us.  National Institutes of Health (NIH).  [ONLINE]
[5/2/01, last day accessed.]

Pielop, J., A.C. Wood, and S. Hsu.  2000.  Update on antiviral therapy for herpes simplex virus infection. Dermatologic Therapy.  13:235-257.

Pillay, D.  1998.  Emergence and control of resistance to antiviral drugs in resistance in herpes viruses, hepatitis B virus, and HIV.  Communicable Disease and Public Health.  1:5-13.

Pillay, D. and M. Zambon. Antiviral Drug Resistance.  [ONLINE]  [5/2/01, last date accessed.]

Shin, Y.K., G. Cai, A. Weinberg, J.J. Leary, and M.J. Levin.  2001.  Frequency of Acyclovir-Resistant Herpes Simplex Virus in Clinical Specimens and Laboratory Isolates.  Journal of Clinical Microbiology.  39:913-917.

WebMD. [ONLINE]  [3/27/01, last date accessed.]